Researchers centered at Nagoya University develop a nanowire device able to detect microscopic levels of urinary markers potentially implicated in cancer
Cells communicate with each other through a number of different mechanisms. Some of these mechanisms are well-known: in animals, for example, predatory threats can drive the release of norepinephrine, a hormone that travels through the bloodstream and triggers heart and muscle cells to initiate a “fight-or-flight” response.
A far less familiar mode of cellular transport is the extracellular vesicle (EV). EVs can be thought of as small “chunks” of a cell that are able to pinch off and circulate throughout the body to deliver messenger cargo to other cells. These messengers have become increasingly recognized as crucial mediators of cell-to-cell communication.
In a new study reported in Science Advances, researchers centered at Nagoya University have developed a novel medical device that can efficiently capture these EVs, and potentially use them to screen for cancer.
Video 1: MicroRNA extraction using nanowires
After introducing a urine sample onto the device, extracellular vesicles are captured by a nanowire substrate via electrostatic forces. MicroRNAs can then be directly extracted from the substrate. Takao Yasui
“EVs are potentially useful as clinical markers. The composition of the molecules contained in an EV may provide a diagnostic signature for certain diseases,” lead author Takao Yasui explains. “The ongoing challenge for physicians in any field is to find a non-invasive diagnostic tool that allows them to monitor their patients on a regular basis–for example, a simple urine test.”
Among the many molecules EVs have been found to harbor are microRNAs, which are short pieces of ribonucleic acid that play diverse roles in normal cellular biology. Critically, the presence of certain microRNAs in urine might serve as a red flag for serious conditions such as bladder and prostate cancer. While this important cargo could therefore theoretically aid physicians in cancer diagnoses, there are still many technological hurdles that need to be overcome. One such hurdle: finding a feasible method to capture EVs in sufficient quantities to analyze them in a routine clinical setting.
“The content of EVs in urine is extremely low, at less than 0.01% of the total fluid volume. This is a major barrier to their diagnostic utility,” Yasui notes. Our solution was to embed zinc oxide nanowires into a specialized polymer to create a material that we believed would be highly efficient at capturing these vesicles. Our findings suggest that the device is indeed quite efficient. We obtained a collection rate of over 99%, surpassing ultracentrifugation as well as other methods that are currently being used in the field.”
To test the practicality of their device, the research team compared the microRNAs of EVs isolated from healthy patients with those isolated from patients who were already diagnosed with bladder, prostate, and other forms of cancer. Notably, their technique required only 1 milliliter of urine–far more than the typical “deposit” provided during a routine checkup–and found a substantially greater number and different types of microRNAs compared with the standard ultracentrifugation approach.
Figure 2: Identification of distinct microRNA patterns in healthy donors and cancer patients
Nanowire extraction allowed many microRNAs to be compared at once using urine samples collected from patients. Expression of each microRNA is shown as low/downregulated (blue), intermediate (black), or high/upregulated (yellow). The analysis reveals unique patterns of expression for groups of microRNAs when comparing healthy donors (?) with cancer patients (+). via Takao Yasui
“Finding a specific, reproducible marker to help confirm a cancer diagnosis is difficult. This is especially true for microRNAs, which are a relatively new class of markers in the field,” co-author Yoshinobu Baba explains. “Sometimes finding just one reliable microRNA is considered a success. Using this approach, we were surprised to find that not just one, but whole combinations of microRNAs might be associated with different types of cancers. The findings are preliminary, of course, but we hope our device can help to lay the groundwork for easier ways to diagnose life-threatening diseases as early as possible.”
The Latest on: Detecting cancer
- The Hunter needs another Little Prick campaign to improve prostate cancer detection rates on May 22, 2019 at 6:00 pm
THE message behind the 'Little Prick' campaign has been forgotten, leaving Hunter men vulnerable to return to the high prostate cancer mortality rates of almost 20 years ago, Professor Jim Denham says ... […]
- AI Beats Radiologists in Detecting Lung Cancer, Study Finds on May 22, 2019 at 1:59 pm
Researchers recently conducted a study in which they trained an artificial intelligence (AI) deep learning tool to detect lung cancer tumors in computed tomography scans. The algorithm's evaluation ... […]
- New Technique Promises Improved Metastatic Prostate Cancer Detection on May 22, 2019 at 10:35 am
Prostate cancer is the second-leading cause of male cancer deaths worldwide. Deaths from prostate cancer are primarily due to metastasized cancer, in which cancer cells have migrated through the body ... […]
- Google Develops Deep Learning Tool to Enhance Lung Cancer Detection on May 22, 2019 at 6:31 am
May 22, 2019 - A deep learning tool built by researchers at Google detected lung cancer as well as or better than human radiologists, showing the potential for AI to boost chances of survival for ... […]
- New fluorescent sensor can detect migrating cancer cells on May 22, 2019 at 2:20 am
A new fluorescent sensor developed by researchers from the University of Adelaide can detect migrating cancer cells and could be used to target medication to stop metastasis in aggressive cancers. ... […]
- Artificial intelligence better than humans at spotting lung cancer on May 21, 2019 at 5:13 am
Researchers have used a deep-learning algorithm to detect lung cancer accurately from computed tomography scans. The results of the study indicate that artificial intelligence can outperform human ... […]
- Google AI outperforms radiologists at lung cancer detection on May 20, 2019 at 4:35 pm
San Jose, Calif. (KTVU) - Google has a couple of high-profile use-cases for AI in healthcare – in detecting eye and heart disease. In a research paper released Monday, Google has shown that its deep ... […]
- Brainstorm Health: A.I. Lung Cancer Detection, Facebook Disease Prevention, Doctor Job Market on May 20, 2019 at 2:45 pm
Happy Monday, readers! I hope you enjoyed your weekend. The machines just aced a major test in the world of cancer detection. A joint collaboration between Google A.I. scientists and medical ... […]
- New Google AI can detect lung cancer in CT scans on May 20, 2019 at 12:22 pm
Google LLC has built an artificial intelligence model that can analyze CT scans of people’s chests to determine if they might have lung cancer. The software, which the company detailed in a blog ... […]
- Google's AI can detect lung cancer better than radiologists on May 20, 2019 at 11:32 am
Artificial intelligence is officially joining the fight against cancer. Google on Monday announced new research in training an AI tool to recognize the signs of lung cancer from a CT scan of a ... […]
via Google News and Bing News